These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21747305)

  • 21. [Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
    Ransmayr G; Katzenschlager R; Dal-Bianco P; Wenning G; Bancher C; Jellinger K; Schmidt R; Poewe W
    Neuropsychiatr; 2007; 21(2):63-74. PubMed ID: 17640492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the societal impact of acetylcholinesterase inhibitor therapies.
    Winblad B; Wimo A
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S9-19. PubMed ID: 10622674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
    Grossberg GT
    Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical basis for symptomatic treatment of Alzheimer's disease.
    Francis PT; Ramírez MJ; Lai MK
    Neuropharmacology; 2010; 59(4-5):221-9. PubMed ID: 20156462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].
    Rösler M; Frey U
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):78-83. PubMed ID: 11823923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supportive care for the patient with Alzheimer's disease.
    Jann MW; Brandt N
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S50-1. PubMed ID: 11029868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
    Davis KL
    Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of neuropsychiatric symptoms in Alzheimer's disease].
    Kaufer D
    Rev Neurol; 2002 Nov 1-15; 35(9):846-50. PubMed ID: 12436383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.
    Loi SM; Eratne D; Kelso W; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):358-365. PubMed ID: 29671334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advance care planning and anticipatory decision making in patients with Alzheimer disease.
    Slyer JT; Archibald E; Moyo F; Truglio-Londrigan M
    Nurse Pract; 2018 Jun; 43(6):23-31. PubMed ID: 29757832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.